First published online June 7, 2004
Journal of Experimental Biology 207, 2389-2400 (2004)
Published by The Company of Biologists 2004
doi: 10.1242/jeb.01036
Development and steroid regulation of RFamide immunoreactivity in antennal-lobe neurons of the sphinx moth Manduca sexta
Joachim Schachtner1,*,
Björn Trosowski1,
Wolfgang D'Hanis1,
Stephan Stubner2 and
Uwe Homberg1
1 Department of Biology, Animal Physiology, Philipps-University, 35032
Marburg, Germany
2 Department of Biogeochemistry, MPI for Terrestrial Microbiology, 35043
Marburg, Germany

View larger version (114K):
[in a new window]
|
Fig. 1. Normarski images of 40 µm sections showing cell types IV of the
AL labeled with the RFamide antiserum. (A) Type I cells in the lateral cell
group (LC) of a stage P15 AL. Staining within the glomeruli (GL) primarily
results from type I neurons. No immunostaining is visible in the median cell
group (MC). (B,C) Consecutive horizontal sections through a P13 AL. (B) In
addition to glomerular staining, type I cell bodies give rise to stained
fibers in the root of the outer antenno-cerebral tract (arrows). (C) Section
ventral to B. The large cell body of the type II cell (arrow) has a
posterior-medial position within the LC. Inset shows the primary neurite
(arrows) leaving the AL without sending processes to the AL neuropil.
(Diiii) Type IIV neurons in a stage P1 pupa. Di and Dii are both
superimposed images of two consecutive sections. Diii combines Di and Dii
(total of four consecutive sections) with parts of the anterior laying cell
groups omitted to better see the connections between cell bodies and neurites.
The neurite (double arrow in Di) of the type II cell (large arrow in Dii, iii)
leaves the AL towards the tritocerebrum (TC) while the neurite of the type V
neuron (double arrowhead in Di) enters the AL. The neurite (arrowheads in Di)
of the type IV neuron gives rise to processes that cover most of the
developing AL area (solid outline in Di). The cell bodies of type II, III
(arrowheads in Dii, iii), and IV neurons (small arrows in Dii, iii) are
located anteriorly to the AL neuropil. Small arrow in Di, Dii points toward
the connection site of the type IV neuron with its cell body. The type IV cell
body lies in a cell group (broken outline in Dii), which is different from
that of type II and III neurons (solid outline in Dii). A, anterior; D,
dorsal; L, lateral; CN, coarse neuropil; MGC, male specific macroglomerular
complex; TC, tritocerebrum. Scale bars, 100 µm (AC); 50 µm (inset
in B, Diiii).
|
|

View larger version (59K):
[in a new window]
|
Fig. 2. Confocal images of 40 µm sections showing double immunostaining in the
lateral cell group (LC) of P10 antennal lobes with antisera against RFamide
(green, Cy2; Ai, Bi) and GABA (red, Cy3; Aiii, Biii). (Aii, Bii) Overlays of
the respective immunostainings in Ai/Aiii and Bi/Biii. (A) RFamide-ir cell
bodies in the LC, of which two show double labeling with the GABA antiserum
(large arrows in Aii). The arrowhead (Ai) points to the large type II cell
body, which like the root of the outer antenno-cerebral tract (small arrows)
shows only RFamide and no GABA immunostaining. (B) In another section all type
I cells colocalize RFamide and GABA immunoreactivity. Scale bars, 40
µm.
|
|

View larger version (109K):
[in a new window]
|
Fig. 3. Confocal images of 40 µm sections showing RFamide immunoreactivity
(green, Cy2) during AL development. (A) Area of the larval antennal center
(LAC) in a wandering larva (W2, 2-day-old wandering stage shortly before
entering the prepupal stage). Within the developing lateral cell group (LC,
encircled area) type II (arrow) and III (arrowheads) somata are stained. The
LAC is labeled (red) by dextran backfill of the antennal nerve. The double
arrowhead marks a dextran-labeled axon bundle coming from the larval antenna.
(BF) Double immunolabeling with the RFamide antiserum (green, Cy2) and
the synaptotagmin antibody (red, Cy5). (B) Anterior section through the
developing AL showing the type V neuron entering the AL from the tritocerebrum
(TC). (C) In stage P9 developing glomeruli (GL) can be distinguished by
synaptotagmin immunostaining. RFamide immunostaining in basal parts of the
developing glomeruli is weak compared to staining of the type V arborizations
(arrowheads) and to staining intensity in stages later than P12/13 (see
DE). In the LC the large type II cell (large arrow) with its neurite
leaving the AL (smaller arrows) and smaller type I cells are labeled. (D)
Frontal section through posterior parts of a stage P16 AL with strongly
labeled type I cells, strong labeling in the glomeruli (GL) and intensely
labeled fibers in the root of the outer antenno-cerebral tract (arrows). (E)
Oblique section showing typical labeling of glomeruli in an adult AL. The type
V cell enters the AL neuropil from the TC (arrow). (F) Magnification from E
showing the neurite of the type V cell entering the AL neuropil. AE,
frontal sections; orientation bars in C (D, dorsal; M, medial) also apply to
AD; CN, coarse neuropil; Es, Esophagus; MC, median cell group; MGC,
macroglomerular complex. Scale bars, 40 µm (A,B); 80 µm (CE); 20
µm (F).
|
|

View larger version (17K):
[in a new window]
|
Fig. 4. Developmental time course of numbers of RFamide-ir cell bodies in the
lateral cell group. Acquisition of RFamide immunostaining in AL neurons occurs
in two phases. A first increase from stage P5 to P7/8 results in about 25
cells. The second increase in cell number (up to about 60 cells) occurs from
P11/12 to P16. Each data point indicates mean ± S.D. The
number of antennal lobes is indicated at each stage; stages P0+P1 and P2+P3
were pooled. The three cells at stages P0 to P4 are the type II and III
neurons. The dotted line indicates adult eclosion at stage P20. Inset shows
hemolymph concentrations of 20E during the pupaladult transition as
reported by Warren and Gilbert
(1986 ). The open and filled
large arrows mark the times of 20E injection at P1, P9 (asterisk) and P10/11,
respectively, the open and filled circles (asterisk after P9 injection) mark
the times when the injected animals were killed and processed for
immunocytochemistry (see Fig.
5).
|
|

View larger version (14K):
[in a new window]
|
Fig. 5. Numbers of RFamide-ir neurons in the AL of M. sexta after
hemolymph injection of 20E at P1 (A), P9 and P10/11 (B) and dissection several
days later (see inset in Fig.
4). (A) Animals were injected with 20E at stage P1 and dissected 2
(P3) to 8/9 days (P9/10) later. Hormone-treated animals (open circles) showed
a progressive increase in the numbers of RFamide-ir neurons compared to
controls (filled circles) injected with saline. (B) Injections of 20E at P9 or
P10/11 and dissection 6/7 days later (P9, open triangles) or 3/45/6
days later (P10/11, open circles) resulted in cell numbers that were not
significantly different from the control animals (filled circles or
triangles). Values are means ± S.D. The number of Als is
shown for each stage. Inset in B shows wing pigmentation 6 days after
injection of saline (control) or 20E at stage P10/11.
|
|

View larger version (61K):
[in a new window]
|
Fig. 6. Confocal images of 40 µm sections showing RFamide immunoreactivity
(green, Cy2) and synaptotagmin immunoreactivity (red, Cy5) in antennal lobes
(ALs) after hemolymph injection of 20E or after injection of the vehicle alone
at stage P1 and dissection 3 days later at pupal stage P4. In A and B,
additional Normarski images are shown (gray). (A) After injection of the
vehicle alone ALs were indistinguishable from ALs of untreated animals at
stage P4. In the lateral cell group (broken outline) two cell bodies are
labeled. (B) 3 days after 20E injection the number of RFamide-ir cells in the
LC (broken outline) increased to levels normally observed about 2 days later
(see Fig. 5A). The glomerular
pattern reached a stage normally observed at pupal stage P7/8
(Dubuque et al., 2001 ). Arrows
point to developing glomeruli. (C) Posterior section through an AL showing a
dense meshwork of strongly RFamide-ir arborizations, which is normally not
observed in P4 or any other pupal stage. Frontal sections; scale bars, 80
µm (A,B); 40 µm(C). M, medial; D, dorsal.
|
|
© The Company of Biologists Ltd 2004